News & Events


Novadaq Technologies Inc.

in
Novadaq Technologies Inc. announced that Sentara Heart Hospital(R) in Norfolk, Virginia and Sentara Virginia Beach General Hospital in Virginia Beach,Virginia have fully integrated the SPY(R) Imaging System into its cardiac surgical pro

In acute kidney failure, a cell-filled device temporarily replaced the injured cells and cut death rates significantly...

in
In acute kidney failure, a cell-filled device temporarily replaced the injured cells and cut death rates significantly, according to a preliminary study.
 
Action Points: 1.) Explain to patients who ask that a preliminary study found that treatment with an external kidney-assist device in addition to standard therapy improved outcomes for high-risk patients with acute kidney failure.

$125 million nationwide settlement in the average wholesale price (AWP) litigation filed in 2002 by consumers and insurance co.

in
Abbott Laboratories, Amgen Inc., Aventis Pharmaceuticals Inc., Bayer Corporation, Dey, Inc., Pharmacia Corporation, Pharmacia & Upjohn LLC, SICOR, Inc., SICOR Pharmaceuticals, Inc., Watson Pharmaceuticals Inc., CSL Behring LLC, Hoechst Marion Roussel and Baxter Healthcare Corporation agreed to a $125 million nationwide settlement in the average wholesale price (AWP) litigation filed in 2002 by consumers and insurance companies, which claimed the defendants intentionally inflated reports of the average wholesale prices on certain prescription dr

Amgen Inc.

in
Amgen Inc. announced the U.S. Food and Drug Administration has approved updated safety information, including an updated boxed warning in the labeling information for the class of drugs known as erythropoiesis-stimulating agents (ESAs), including Aranesp(R) (darbepoetin alfa) and EPOGEN(R) (Epoetin alfa).

Amgen Inc. to present the benefits and risks of Erythropoiesis-stimulating Agents

in
Amgen Inc. to present the benefits and risks of Erythropoiesis-stimulating Agents (ESAs) in cancer patients with anemia due to concomitantly administered chemotherapy at a meeting with the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC). ESAs provide these patients with the only therapeutic alternative to red blood cell (RBC) transfusions, which have known and uncertain risks.

Nabi Biopharmaceuticals

in
Nabi Biopharmaceuticals (Nasdaq:NABI) announced today a settlement of the patent infringement case against Roxane Laboratories that involved Nabi's former product, PhosLo(r) (calcium acetate) GelCaps. The settlement between Fresenius Medical Care Holdings, Inc., Roxane Laboratories, Inc. and Nabi was made to the mutual satisfaction of all parties and was reviewed and accepted by the U.S. District Court of the Southern District of Ohio.

Patients at dialysis centers can expect an individualized plan...

in
Patients at dialysis centers can expect an individualized plan, electronic health records and defibrillators in every unit under new Medicare rules.   The rules aren't expected to cost dialysis centers more because other provisions will be eliminated, including requirements for a long-term care plan, Barry Straube, Medicare's chief medical officer, said in a telephone news conference Thursday.

Fresenius Medical Care AG & Co. KGaA

in
Fresenius Medical Care AG & Co. KGaA (FMS) announced that it would file appeal against trial court's award of $14.3 million in damages on sale of hemodialysis machines and disposables through October 2007 related to a patent infringement case filed by Baxter International Inc.

Amgen Inc.'s

in
The federal judge overseeing Amgen Inc.'s patent infringement case against Roche Holding AG, ordered that an expert be appointed to recommend how to compare dosing and prices of the two companies' anemia drugs, Reuters reports.
 

Fresenius is in talks to buy Italian group Sorin's renal care business ...

in
Fresenius is in talks to buy Italian group Sorin's renal care business which had sales of 100 million euros ($159 million) last year, the Financial Times Deutschland newspaper reported. The paper quoted industry sources as saying that Fresenius was being advised by Societe Generale while Morgan Stanley was working for Sorin, whose renal care unit makes dialysis machines. More
123456789next ›last »
Syndicate content